E-LIB Suche - Ergebnisse für: Ibrahimi, N.

1

189O A phase II study of patritumab deruxtecan (HER3-DXd), ..:

Pistilli, B. ; Ibrahimi, N. ; Lacroix-Triki, M....
ESMO Open. 8 (2023) 1 - p. 101378 , 2023

Link: https://doi.org/10.1016/..

2

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

3

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

4

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

5

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

6

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

7

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

8

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

9

High p16 expression and heterozygous RB1 loss are biomarker..:

Palafox, M ; Monserrat, L ; Bellet, M...
ARTN 5258. , 2022

Link: https://doi.org/10.1038/..

10

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

11

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

12

Outcomes of Patients With Active Cancer and COVID-19 in the..:

Plais, H ; Labruyère, M ; Creutin, T...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.858276. , 2022

Link: https://inserm.hal.scien..

13

SARCOME DU STROMA ENDOMETRIAL :LOCALISATION SECONDAIRE GAST..:

M. Elkhayari ; H. Abid ; M. Elyousfi...
doi:10.5281/zenodo.8191944. , 2023

Link: https://zenodo.org/recor..

14

Recombinant ADAMTS13: an effective Rescue Therapy for acute..:

Dadoun, Simon E. ; Adam, Karolina ; Hensch, Lisa...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

15

Removal of cadmium from phosphate industrial wastewater usi..:

Radaa, C. ; Jallal, Z. ; Bougdour, N....
International Journal of Environmental Science and Technology. 21 (2024) 11 - p. 7667-7680 , 2024

Link: https://doi.org/10.1007/..